Rabeprazole-induced acute cholestatic liver injury.
Bora
B
Aktaş
Ömer
Ö
Başar
Akif
A
Altinbaş
Fuat
F
Ekiz
Osman
O
Yüksel
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002779:Cholestasis / Q000139:chemically induced*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D064750:Rabeprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064750:Rabeprazole